Moneycontrol Presented by Motilal Oswal
Days hours minutes
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance

Co-Presenting Sponsor

Capital Trade

Powered by


Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
Jan 31, 2017 03:49 PM IST | Source:

Buy Granules India; target of Rs 160: Motilal Oswal

Motilal Oswal is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 160 in its research report dated January 30, 2017.

  • bselive
  • nselive
Todays L/H

Motilal Oswal's research report on Granules India

Finished dosage segment’s revenue grew 33% YoY to INR 1.6b, driven by scale-up in Rx business. Revenue of PFI segment declined 7% YoY, while that of API segment fell 11% YoY to INR 1.2b. Capacity constraints, along with captive consumption of API, led to muted revenue growth. GRAN expects revenues to bounce back, led by expanded capacity in API and PFI segments.

GRAN trades at 10x FY19E EPS. We believe the stock has the potential deliver >50% return over next 12-18 months, led by multiple re-rating (to >15x forward earnings) and strong EPS CAGR of 30%. Our TP of INR 160 is based on 16x 1HFY19E PER.

For all recommendations, click here

The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.
Follow us on
Available On